Department of Ophthalmology, Queen's Hospital, Barking, Havering and Redbridge University Hospitals NHS Trust, Romford, UK.
Korean J Ophthalmol. 2021 Oct;35(5):391-396. doi: 10.3341/kjo.2021.0022. Epub 2021 Aug 3.
To determine the margin of resection (MOR) for periocular basal cell carcinoma (BCC) and compare the outcomes of BCC treatment, namely Mohs micrographic surgery (MMS) and wide excision with later reconstruction (WELR).
This is a retrospective, comparative, interventional study of patients who underwent surgical treatment of periocular BCC. One hundred forty-two patients were included. One hundred patients were treated with MMS and 42 with WELR. Inclusion criteria were primary periocular BCC with postoperative follow-up of ≥6 months, age more than 18-year-old. Exclusion criteria were, orbital extension, BCC origin outside the periocular area, or those associated with Gorling or nevoid BCC. The main outcome measure was variables associates with MOR >4 mm.
There was a positive correlation between the preoperative tumor horizontal and vertical diameter with the corresponding MOR, of 0.27 (p = 0.01) and 0.28 (p = 0.007), respectively. Receiver operating characteristics suggest that a tumor with a horizontal diameter ≥5 mm or a vertical diameter of ≥6 mm, might need MOR >4 mm. One patient in the MMS group had BCC recurrence compared to none in the WELR group, and one patient in the WELR had a positive surgical margin, which was cleared during the reconstruction.
BCC tumor margins may extend far beyond clinical margins and the MOR required is often more than 3-4 mm. MMS ensures clear tumor margins but is not practical for all patients. A stratification system could help divide patients between the treatment strategies.
确定眼部基底细胞癌(BCC)的切除边缘(MOR),并比较 BCC 治疗的结果,即Mohs 显微外科手术(MMS)和广泛切除后重建(WELR)。
这是一项回顾性、比较性、干预性研究,纳入了接受眼部 BCC 手术治疗的患者。共纳入 142 例患者,其中 100 例接受 MMS 治疗,42 例接受 WELR 治疗。纳入标准为原发性眼部 BCC,术后随访≥6 个月,年龄大于 18 岁。排除标准为眼眶延伸、BCC 起源于眼周区域以外、或与 Gorling 或神经嵴 BCC 相关的病例。主要观察指标为与 MOR>4mm 相关的变量。
术前肿瘤的水平和垂直直径与相应的 MOR 呈正相关,分别为 0.27(p=0.01)和 0.28(p=0.007)。受试者工作特征曲线提示,肿瘤的水平直径≥5mm 或垂直直径≥6mm 时,可能需要 MOR>4mm。MMS 组有 1 例 BCC 复发,而 WELR 组无复发,1 例 WELR 组有阳性手术切缘,在重建过程中得到清除。
BCC 肿瘤边缘可能远远超出临床边缘,所需的 MOR 通常大于 3-4mm。MMS 可确保肿瘤边缘清晰,但并非适用于所有患者。分层系统可帮助将患者分为不同的治疗策略。